Premium
Secukinumab in patients with psoriasis who have responded inadequately to tumour necrosis factor inhibitor treatment
Author(s) -
Tsai T.F.
Publication year - 2020
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.18869
Subject(s) - secukinumab , medicine , psoriasis , dermatology , necrosis , tumor necrosis factor alpha , plaque psoriasis , tumor necrosis factor α , psoriatic arthritis
Linked Article: Warren et al . Br J Dermatol 2020; 183 :60–70.